$LCID
Lucid Group, Inc. Stock $lcid

$lcid Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000162828024007209 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$172.7M	$157.2M	$595.3M
YoY Change	15.6%	-39.02%	-2.12%
Cost Of Revenue	$404.8M	$410.0M	$1.936B
YoY Change	-19.13%	-33.36%	17.62%
Gross Profit	-$232.1M	-$252.9M	-$1.341B
YoY Change	-33.9%	-29.28%	29.18%
Gross Profit Margin	-134.34%	-160.91%	-225.24%
Selling, General & Admin	$213.2M	$241.0M	$797.2M
YoY Change	26.34%	41.06%	8.53%
% of Gross Profit
Research & Development	$284.6M	$243.0M	$937.0M
YoY Change	23.86%	9.8%	14.06%
% of Gross Profit
Depreciation & Amortization	$68.84M	$67.50M	$233.5M
YoY Change	38.12%	22.2%	25.16%
% of Gross Profit
Operating Expenses	$497.9M	$484.0M	$1.734B
YoY Change	24.91%	23.42%	11.45%
Operating Profit	-$729.9M	-$736.9M	-$3.100B
YoY Change	-5.47%	-1.72%	19.49%
Interest Expense	$7.501M	$50.90M	$24.92M
YoY Change	5.53%	137.9%	-18.57%
% of Operating Profit
Other Income/Expense, Net	$49.24M	$32.21M	$272.2M
YoY Change	-780.35%	-87.39%	-78.9%
Pretax Income	-$680.7M	-$653.8M	-$2.827B
YoY Change	-12.67%	38.27%	116.81%
Income Tax	$188.0K	$14.00K	$1.026M
% Of Pretax Income
Net Earnings	-$680.9M	-$653.8M	-$2.828B
YoY Change	-12.65%	38.32%	116.83%
Net Earnings / Revenue	-394.15%	-416.01%	-475.15%
Basic Earnings Per Share	-$0.30		-$1.36
Diluted Earnings Per Share	-$0.30	-$0.29	-$1.36
COMMON SHARES
Basic Shares Outstanding	2.300B shares	2.289B shares	2.082B shares
Diluted Shares Outstanding	2.302B shares		2.082B shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.994B	$3.860B	$3.860B
YoY Change	34.11%	-1.36%	-1.36%
Cash & Equivalents	$2.169B	$1.370B	$1.370B
Short-Term Investments	$1.825B	$2.490B	$2.490B
Other Short-Term Assets	$74.89M	$79.67M	$149.4M
YoY Change	27.15%	-2.29%	2.94%
Inventory	$565.7M	$696.2M	$696.2M
Prepaid Expenses	$72.14M	$69.68M
Receivables	$126.9M	$51.82M	$51.82M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.834B	$4.757B	$4.757B
YoY Change	17.33%	-3.15%	-3.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.189B	$3.032B	$3.032B
YoY Change	25.76%	27.31%	27.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$688.4M	$461.0M	$461.0M
YoY Change	55.84%	-13.01%	-13.01%
Other Assets	$185.4M	$262.2M	$262.2M
YoY Change	13.51%	374.07%	374.07%
Total Long-Term Assets	$4.063B	$3.756B	$3.756B
YoY Change	29.35%	26.57%	26.57%
TOTAL ASSETS
Total Short-Term Assets	$4.834B	$4.757B	$4.757B
Total Long-Term Assets	$4.063B	$3.756B	$3.756B
Total Assets	$8.897B	$8.513B	$8.513B
YoY Change	22.53%	8.04%	8.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$101.5M	$108.7M	$108.7M
YoY Change	-30.37%	-52.54%	-52.54%
Accrued Expenses	$226.7M	$92.49M	$92.49M
YoY Change	125.3%	46.07%	46.07%
Deferred Revenue
YoY Change
Short-Term Debt	$72.52M	$72.53M	$72.53M
YoY Change	655.85%	655.95%	655.95%
Long-Term Debt Due	$7.548M	$8.202M	$8.202M
YoY Change	-26.28%	-22.52%	-22.52%
Total Short-Term Liabilities	$1.037B	$1.008B	$1.008B
YoY Change	2.14%	7.56%	7.56%
LONG-TERM LIABILITIES
Long-Term Debt	$1.998B	$1.997B	$2.075B
YoY Change	0.26%	0.26%	0.07%
Other Long-Term Liabilities	$525.9M	$524.3M	$578.0M
YoY Change	45.78%	38.64%	11.41%
Total Long-Term Liabilities	$2.524B	$2.521B	$2.653B
YoY Change	7.23%	6.38%	2.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.037B	$1.008B	$1.008B
Total Long-Term Liabilities	$2.524B	$2.521B	$2.653B
Total Liabilities	$4.160B	$3.661B	$3.661B
YoY Change	14.64%	3.73%	3.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.90B	-$10.20B
YoY Change	34.57%	37.84%
Common Stock	$231.0K	$230.0K
YoY Change	26.23%	25.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.232B	$4.852B	$4.852B
YoY Change
Total Liabilities & Shareholders Equity	$8.897B	$8.513B	$8.513B
YoY Change	22.53%	8.04%	8.04%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$680.9M	-$653.8M	-$2.828B
YoY Change	-12.65%	38.32%	116.83%
Depreciation, Depletion And Amortization	$68.84M	$67.50M	$233.5M
YoY Change	38.12%	22.2%	25.16%
Cash From Operating Activities	-$516.7M	-$474.6M	-$2.490B
YoY Change	-35.51%	-26.82%	11.84%
INVESTING ACTIVITIES
Capital Expenditures	$198.2M	$272.6M	$910.6M
YoY Change	-18.02%	-5.95%	-15.28%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$924.8M	$4.827M
YoY Change	-100.0%	-999.88%	-100.19%
Cash From Investing Activities	$317.5M	$652.2M	-$947.0M
YoY Change	-1205.82%	-266.09%	-74.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$997.2M	27.95M	$3.071B
YoY Change	-17457.74%	-98.15%	127.94%
NET CHANGE
Cash From Operating Activities	-$516.7M	-474.6M	-$2.490B
Cash From Investing Activities	$317.5M	652.2M	-$947.0M
Cash From Financing Activities	$997.2M	27.95M	$3.071B
Net Change In Cash	$798.0M	205.6M	-$365.8M
YoY Change	-195.49%	-56.42%	-91.98%
FREE CASH FLOW
Cash From Operating Activities	-$516.7M	-$474.6M	-$2.490B
Capital Expenditures	$198.2M	$272.6M	$910.6M
Free Cash Flow	-$714.9M	-$747.2M	-$3.400B
YoY Change	-31.46%	-20.38%	3.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.36
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.36
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-11572000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3753000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11572000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2579761000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2811998000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1316032000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001811210
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	2489798000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2177231000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsCurrent
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39408
CY2023	dei	Entity Registrant Name EntityRegistrantName	Lucid Group, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0891392
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7373 Gateway Boulevard
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94560
CY2023	dei	City Area Code CityAreaCode	510
CY2023	dei	Local Phone Number LocalPhoneNumber	648-3553
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	LCID
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6100000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2300047548	shares
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Santa Clara, California
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	San Francisco, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1369947000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1735765000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51822000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19542000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	696236000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	834401000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	69682000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	63548000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	79670000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	81541000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4757155000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4912028000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2810867000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2166776000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	221508000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	215160000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	461029000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	529974000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	262159000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55300000	usd
CY2023Q4	us-gaap	Assets Assets	8512718000	usd
CY2022Q4	us-gaap	Assets Assets	7879238000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	108724000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	229084000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	92494000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63322000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8202000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10586000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	798990000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	634567000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1008410000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	937559000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	77653000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	81336000	usd
CY2023Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	53664000	usd
CY2022Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	140590000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1996960000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1991840000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	524339000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	378212000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2300111489	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1830172561	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2299253664	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1829314736	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	230000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	183000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15066080000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11752138000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	857825	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	857825	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20716000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20716000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4850000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11572000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10198752000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7370332000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4851692000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4349701000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8512718000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7879238000	usd
CY2023	us-gaap	Revenues Revenues	595271000	usd
CY2022	us-gaap	Revenues Revenues	608181000	usd
CY2021	us-gaap	Revenues Revenues	27111000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1936066000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1646086000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	154897000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	937012000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	821512000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	750185000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	797235000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	734574000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	652475000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	24546000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	3694859000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	3202172000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	1557557000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3099588000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2593991000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1530446000	usd
CY2023	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
CY2022	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
CY2021	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454546000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	5999000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2023	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	usd
CY2022	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	usd
CY2021	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2717000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	204274000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	56756000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	24915000	usd
CY2022	us-gaap	Interest Expense InterestExpense	30596000	usd
CY2021	us-gaap	Interest Expense InterestExpense	1374000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9532000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-893000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	272194000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1289910000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1049266000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2827394000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1304081000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2579712000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1026000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	379000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2828420000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1304460000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2828420000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1304460000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4747093000	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	-1254218000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2828420000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2558678000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4747093000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2081772622	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1678346079	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740393759	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2081772622	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1693258608	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740393759	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.41
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.41
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12669000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	16422000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2023	lcid	Comprehensive Income Loss Available To Common Stockholders ComprehensiveIncomeLossAvailableToCommonStockholders	-2811998000	usd
CY2022	lcid	Comprehensive Income Loss Available To Common Stockholders ComprehensiveIncomeLossAvailableToCommonStockholders	-1316032000	usd
CY2021	lcid	Comprehensive Income Loss Available To Common Stockholders ComprehensiveIncomeLossAvailableToCommonStockholders	-4747093000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2151613000	usd
CY2021	lcid	Reclassifications Of Temporary To Permanent Equity Shares ReclassificationsOfTemporaryToPermanentEquityShares	1155909367	shares
CY2021	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	5836785000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5836785000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590956000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	22063000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	20716000	usd
CY2021	lcid	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	173273000	usd
CY2021	lcid	Warrants Redeemed Or Called During Period Value WarrantsRedeemedOrCalledDuringPeriodValue	4000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8132000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	393143000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1304460000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11572000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	218789000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	24562000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17788000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	423500000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4349701000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2828420000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	16422000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17615000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	23836000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10343000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	300560000	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4851692000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2828420000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1304460000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	usd
CY2023	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	233531000	usd
CY2022	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	186583000	usd
CY2021	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	62907000	usd
CY2023	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	39507000	usd
CY2022	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	35620000	usd
CY2021	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	18474000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26201000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	19711000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	12563000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	257283000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	423500000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	516757000	usd
CY2023	lcid	Inventory And Purchase Obligation Write Down Noncash InventoryAndPurchaseObligationWriteDownNoncash	906069000	usd
CY2022	lcid	Inventory And Purchase Obligation Write Down Noncash InventoryAndPurchaseObligationWriteDownNoncash	569479000	usd
CY2021	lcid	Inventory And Purchase Obligation Write Down Noncash InventoryAndPurchaseObligationWriteDownNoncash	48884000	usd
CY2023	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	0	usd
CY2022	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	0	usd
CY2021	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-454546000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	105432000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	20695000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	5999000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-34205000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-10353000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-289000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32509000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16498000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2888000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	658010000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1256349000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	175091000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	45641000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	28822000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	66980000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4758000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	43591000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14704000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	121790000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	43230000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5889000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-139519000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	180469000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4354000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	29172000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	30958000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16167000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-71680000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	253904000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	55437000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	75447000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	31028000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4712000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2489753000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2226258000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1058133000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	910644000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1074852000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	421220000	usd
CY2023	lcid	Proceeds From Government Grant ProceedsFromGovernmentGrant	97500000	usd
CY2022	lcid	Proceeds From Government Grant ProceedsFromGovernmentGrant	97267000	usd
CY2021	lcid	Proceeds From Government Grant ProceedsFromGovernmentGrant	0	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3998282000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3854129000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3720890000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1149714000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	148388000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	505000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4827000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-323000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-22000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-946975000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3681677000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-420693000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2002437000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	41935000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15330000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	27887000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5425000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4977000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3088000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	62911000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	29818000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20223000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	0	usd
CY2022	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	31700000	usd
CY2021	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10343000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17788000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8132000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173273000	usd
CY2023	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
CY2022	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
CY2021	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439153000	usd
CY2023	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	0	usd
CY2022	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	0	usd
CY2021	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	38865000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	23836000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	24562000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20716000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17615000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	218789000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	22063000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7136428000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4560700000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5657602000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1371507000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1737320000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	18182000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	23199000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	627000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	480000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	35849000	usd
CY2022	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	42728000	usd
CY2021	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	101057000	usd
CY2023	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	32477000	usd
CY2022	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	157894000	usd
CY2021	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	93771000	usd
CY2023	lcid	Equity Securities Obtained Through Arrangement EquitySecuritiesObtainedThroughArrangement	73193000	usd
CY2022	lcid	Equity Securities Obtained Through Arrangement EquitySecuritiesObtainedThroughArrangement	0	usd
CY2021	lcid	Equity Securities Obtained Through Arrangement EquitySecuritiesObtainedThroughArrangement	0	usd
CY2023	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	usd
CY2022	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	usd
CY2021	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	9936000	usd
CY2023	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	usd
CY2022	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	usd
CY2021	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	2167332000	usd
CY2023	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	usd
CY2022	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	usd
CY2021	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	15719000	usd
CY2023	lcid	Issuance Of Convertible Preferred Stock Upon Settlement Of Contingent Forward Contracts IssuanceOfConvertiblePreferredStockUponSettlementOfContingentForwardContracts	0	usd
CY2022	lcid	Issuance Of Convertible Preferred Stock Upon Settlement Of Contingent Forward Contracts IssuanceOfConvertiblePreferredStockUponSettlementOfContingentForwardContracts	0	usd
CY2021	lcid	Issuance Of Convertible Preferred Stock Upon Settlement Of Contingent Forward Contracts IssuanceOfConvertiblePreferredStockUponSettlementOfContingentForwardContracts	2621877000	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	5836785000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF BUSINESS</span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid Group, Inc. (“Lucid”) is a technology company focused on designing, developing, manufacturing, and selling the next generation of electric vehicles (“EV”), EV powertrains and battery systems.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid was originally incorporated in Delaware on April 30, 2020 under the name Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (“Churchill”) as a special purpose acquisition company with the purpose of effecting a merger with one or more operating businesses. On February 22, 2021, Churchill entered into a definitive merger agreement (the “Merger Agreement”) with Atieva, Inc. (“Legacy Lucid”) in which Legacy Lucid would become a wholly owned subsidiary of Churchill (the “Merger”). Upon the closing of the Merger on July 23, 2021 (the “Closing”), Churchill was immediately renamed to “Lucid Group, Inc.” The Merger between Churchill and Legacy Lucid was accounted for as a reverse recapitalization. See Note 4 “Reverse Recapitalization” for more information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the notes to the consolidated financial statements, unless otherwise noted, the “Company,” “we,” “us” or “our” and similar terms refer to Legacy Lucid and its subsidiaries prior to the consummation of the Merger, and Lucid and its subsidiaries after the consummation of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company devotes its efforts to business planning, selling and servicing of vehicles, providing technology access, research and development, construction and expansion of manufacturing facilities, expansion of retail studios and service center capacities, recruiting of management and technical staff, acquiring operating assets, and raising capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2023, the Company has incurred operating losses and negative cash flows from operating activities. For the years ended December 31, 2023, 2022 and 2021, the Company has incurred net losses of $2.8 billion, $1.3 billion and $2.6 billion, respectively. The Company had an accumulated deficit of $10.2 billion as of December 31, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the first phase of the construction of its Advanced Manufacturing Plant-1 in Casa Grande, Arizona (“AMP-1”) in 2021, transitioned general assembly to the AMP-1 phase 2 manufacturing facility and completed the semi knocked-down (“SKD”) portion of its Advanced Manufacturing Plant-2 in Saudi Arabia (“AMP-2”) in September 2023. The Company began commercial production of its first vehicle, the Lucid Air, in September 2021 and delivered its first vehicles in late October 2021. The Company continues to expand AMP-1, construct the completely-built-up (“CBU”) portion of AMP-2, and build a network of retail sales and service locations. The Company has plans for continued development of additional vehicle model types for future release. The aforementioned activities will require considerable capital, which is above and beyond the expected cash inflows from the initial sales of the Lucid Air. As such, the future operating plan involves considerable risk if secure funding sources are not identified and confirmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s existing sources of liquidity include cash, cash equivalents, investments, and credit facilities. Historically, the Company funded operations primarily with issuances of common stock, convertible preferred stock and convertible notes. Upon the completion of the Merger, the Company received $4,400.3 million in cash proceeds, net of transaction costs. In December 2021, the Company issued an aggregate principal amount of $2,012.5 million of 1.25% convertible senior notes due in December 2026. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company entered into a loan agreement with the Saudi Industrial Development Fund (“SIDF”) with an aggregate principal amount of up to approximately $1.4 billion, a five-year senior secured asset-based revolving credit facility (“ABL Credit Facility”) with an initial aggregate principal commitment amount of up to $1.0 billion and revolving credit facilities (the “GIB Facility Agreement”) with Gulf International Bank (“GIB”) in an aggregate principal amount of approximately $266.1 million. The GIB Facility Agreement provided for two committed revolving credit facilities, of which $173.0 million was available as a bridge financing (the “Bridge Facility”) and $93.1 million was for general corporate purposes (the “Working Capital Facility”). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company amended the GIB Facility Agreement (together with the GIB Facility Agreement, the “Amended GIB Facility Agreement”) to combine the Bridge Facility and the Working Capital Facility into a committed $266.7 million revolving credit facility (the “GIB Credit Facility”), which will bear interest at a rate of 1.40% per annum over SAIBOR (based on the term of borrowing) and associated fees. See Note 7 “Debt” for more information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2022, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with BofA Securities, Inc., Barclays Capital Inc. and Citigroup Global Markets Inc., under which the Company could offer and sell shares of its common stock having an aggregate offering price up to $600.0 million (the “At-the-Market Offering”). On November 8, 2022, the Company also entered into a subscription agreement (the “2022 Subscription Agreement”) with Ayar Third Investment Company, the controlling stockholder of the Company (“Ayar”), pursuant to which Ayar agreed to purchase from the Company, up to $915.0 million of shares of its common stock in one or more private placements through March 31, 2023. In December 2022, the Company completed its At-the-Market Offering program pursuant to the Equity Distribution Agreement for net proceeds of $594.3 million after deducting commissions and other issuance costs and also consummated a private placement of shares to Ayar pursuant to the 2022 Subscription Agreement for $915.0 million. No shares remain available for sale under the Equity Distribution Agreement. See Note 12 “Stockholders’ Equity” for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 31, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc. (the “Underwriter”), under which the Underwriter agreed to purchase from the Company shares of the Company’s common stock in a public offering for aggregate net proceeds to the Company of $1.2 billion. On May 31, 2023, the Company also entered into a subscription agreement (the “2023 Subscription Agreement”) with Ayar, pursuant to which Ayar agreed to purchase from the Company shares of the Company’s common stock in a private placement for aggregate net proceeds of $1.8 billion. In June 2023, the Company completed the public offering pursuant to the Underwriting Agreement for aggregate net proceeds of $1.2 billion and also consummated the private placement to Ayar pursuant to the 2023 Subscription Agreement for aggregate net proceeds of $1.8 billion. See Note 12 “Stockholders’ Equity” for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s current business activities consist of (i) generating sales from the deliveries and service of vehicles, (ii) research and development efforts to design, engineer and develop high-performance fully electric vehicles and advanced electric vehicle powertrain components, including battery pack systems, (iii) further construction of AMP-1 phase 2 in Casa Grande, Arizona, (iv) construction of the CBU portion of AMP-2 in Saudi Arabia, (v) expansion of its retail studios and service centers capabilities throughout North America and across the globe, and (vi) providing its technology access to third parties. The Company is subject to the risks associated with such activities, including the need to further develop its technology, its marketing, and distribution channels; further develop its supply chain and manufacturing; and hire additional management and other key employees. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including our ability to access potential markets, and secure long-term financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participates in a dynamic high-technology industry. Changes in any of the following areas could have a material adverse impact on the Company’s future financial position, results of operations, and/or cash flows: changes in the overall demand for its products and services; advances and trends in new technologies; competitive pressures; acceptance of the Company’s products and services; litigation or claims against the Company based on intellectual property (including patents), regulatory, or other factors; and the Company’s ability to attract and retain employees necessary to support its business operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A global economic recession or other downturn, whether due to inflation, global conflicts or other geopolitical events, COVID-19 or other public health crises, interest rate increases or other policy actions by major central banks, government closures of banks and liquidity concerns at other financial institutions, or other factors, may have an adverse impact on the Company’s business, prospects, financial condition and results of operations. Adverse economic conditions as well as uncertainty about the current and future global economic conditions may cause the Company’s customers to defer purchases or cancel their reservations and orders in response to higher interest rates, availability of consumer credit, decreased cash availability, fluctuations in foreign currency exchange rates, and weakened consumer confidence. Reduced demand for the Company’s products may result in significant decreases in product sales, which in turn would have a material adverse impact on the Company’s business, prospects, financial condition and results of operations. Because of the Company’s premium brand positioning and pricing, an economic downturn is likely to have a heightened adverse effect on the Company compared to many of its electric vehicle and traditional automotive industry competitors, to the extent that consumer demand for luxury goods is reduced in favor of lower-priced alternatives. In addition, any economic recession or other downturn could also cause logistical challenges and other operational risks if any of the Company’s suppliers, sub-suppliers or partners become insolvent or are otherwise unable to continue their operations, fulfill their obligations to the Company, or meet the Company’s future demand. In addition, the deterioration of conditions in the broad financing markets may limit the Company’s ability to obtain external financing to fund its operations and capital expenditures on terms favorable to the Company, if at all. See “Risk Factors” in Item 1A of Part I of this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual Report </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Form 10-K (the “Annual Report”) for more information regarding risks associated with a global economic recession, including under the caption “</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A global economic recession, government closures of banks and liquidity concerns at other financial institutions, or other downturn may have a material adverse impact on our business, prospects, results of operations and financial condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current circumstances, any impact on the Company’s financial condition, results of operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are highly uncertain and cannot be predicted with accuracy.</span></div>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2800000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1300000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2600000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10200000000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include, among others, inventory valuation, warranty reserve, useful lives of property, plant and equipment, fair value of common stock warrants, fair value of contingent forward contracts liability, estimates of residual value guarantee (“RVG”) liability, deferred revenue related to technology access fees and over-the-air (“OTA”) software updates, sales return reserves, fair value of common stock prior to the Merger and other assumptions used to measure stock-based compensation expense, and estimated incremental borrowing rates for assessing operating and finance leases. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
CY2023Q4	us-gaap	Cash Cash	1369947000	usd
CY2022Q4	us-gaap	Cash Cash	1735765000	usd
CY2021Q4	us-gaap	Cash Cash	6262905000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1560000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1555000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10740000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24375000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1371507000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1737320000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, investments and accounts receivable. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits, but at times its deposits may exceed federally insured limits.
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, including property, plant and equipment and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">right-of-use (“ROU”) assets </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for potential impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount of the underlying asset exceeds its fair value. The Company recognized impairment loss of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$15.3 million</span><span style="color:#b6b6b6;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023. I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mpairment loss recognized for the years ended December 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2021 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immaterial.</span></div>
CY2023	lcid	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	impairment loss
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	15300000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	lcid	Number Of Performance Obligations NumberOfPerformanceObligations	2	obligation
CY2023	lcid	Basic Vehicle Warranty Term BasicVehicleWarrantyTerm	P4Y
CY2023	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div>The Company provides a manufacturer’s warranty on all vehicles it sells and accrues a warranty reserve for warranty coverage, as applicable. These estimates are based on actual claims incurred to date and an estimate of the nature, frequency, and costs of future claims. The Company accrues a warranty reserve for all products sold which includes the Company’s best estimates of the projected costs related to recalls identified and special campaigns to repair or replace items under warranties. Changes to the Company’s historical or projected warranty experience may cause material changes to the warranty reserve in the future. The portion of the warranty reserve for costs expected to be incurred within the next 12 months is included within other current liabilities, while the remaining balance is included within other long-term liabilities in the consolidated balance sheets. The warranty expense is recorded as a component of cost of revenue in the consolidated statements of operations and comprehensive loss.
CY2023	us-gaap	Advertising Expense AdvertisingExpense	35300000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	24500000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023	lcid	Restructuring Charges Excluding Non Cash RestructuringChargesExcludingNonCash	25989000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	25935000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	54000	usd
CY2023	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	1400000	usd
CY2023	lcid	Share Based Payment Arrangement Accelerated Expense ShareBasedPaymentArrangementAcceleratedExpense	3400000	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	2.644
CY2021Q3	lcid	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments And Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsAndOptionsOutstandingNumber	42182931	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	437182072	shares
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	437182072	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25764610	shares
CY2021Q3	lcid	Share Based Payment Award Options Converted ShareBasedPaymentAwardOptionsConverted	68121210	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	16418321	shares
CY2021Q3	lcid	Share Based Payment Award Non Option Equity Instruments Converted Reverse Recapitalization ShareBasedPaymentAwardNonOptionEquityInstrumentsConvertedReverseRecapitalization	43409870	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	lcid	Reverse Recapitalization Working Capital Loan Converted Amount ReverseRecapitalizationWorkingCapitalLoanConvertedAmount	1500000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500000	shares
CY2021Q3	lcid	Debt Conversion Converted Instrument Warrants Or Options Issued Price Per Warrant DebtConversionConvertedInstrumentWarrantsOrOptionsIssuedPricePerWarrant	1.00
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	1193226511	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85750000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439200000	usd
CY2021Q3	lcid	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	2070100000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	us-gaap	Cash Cash	400000	usd
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000	usd
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	21644	shares
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Incurred ReverseRecapitalizationTransactionCostsIncurred	38900000	usd
CY2021Q3	lcid	Adjustments To Additional Paid In Capital Reduction For Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReductionForReverseRecapitalizationTransactionCosts	36200000	usd
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2700000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	210283000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	464731000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53227000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	34311000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	432726000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	335359000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	696236000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	834401000	usd
CY2023	lcid	Inventory And Purchase Obligation Write Down InventoryAndPurchaseObligationWriteDown	926900000	usd
CY2022	lcid	Inventory And Purchase Obligation Write Down InventoryAndPurchaseObligationWriteDown	569500000	usd
CY2021	lcid	Inventory And Purchase Obligation Write Down InventoryAndPurchaseObligationWriteDown	48900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	3312268000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	2439866000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	501401000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	273090000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2810867000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	2166776000	usd
CY2023	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	233500000	usd
CY2022	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	186600000	usd
CY2021	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	62900000	usd
CY2023Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	42176000	usd
CY2022Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	28686000	usd
CY2023Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	156414000	usd
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	167462000	usd
CY2023Q4	lcid	Accrued Purchases AccruedPurchases	44957000	usd
CY2022Q4	lcid	Accrued Purchases AccruedPurchases	157162000	usd
CY2023Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	6005000	usd
CY2022Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	9099000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	41478000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	34951000	usd
CY2023Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	49925000	usd
CY2022Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	21714000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	72533000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	9595000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28431000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11269000	usd
CY2023Q4	lcid	Loss Reserve On Firm Commitments Current LossReserveOnFirmCommitmentsCurrent	143566000	usd
CY2022Q4	lcid	Loss Reserve On Firm Commitments Current LossReserveOnFirmCommitmentsCurrent	22640000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	22677000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	10464000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	190828000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	161525000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	798990000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	634567000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	244122000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	243843000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	280217000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	134369000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	524339000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	378212000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	22949000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1282000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	50923000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11557000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	74050000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	33224000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	46076000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	22949000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	11100000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	7500000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2491627000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2489798000	usd
CY2023Q4	lcid	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	458117000	usd
CY2023Q4	lcid	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	461029000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	2949744000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	2950827000	usd
CY2021	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454500000	usd
CY2021Q2	us-gaap	Share Price SharePrice	23.78
CY2017Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000000	usd
CY2021Q1	lcid	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	12900000	usd
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1316758889	shares
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1155909398	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted After Exchange Ratio Reverse Recapitalization StockConvertedAfterExchangeRatioReverseRecapitalization	1155909367	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	lcid	Common Stock Voting Rights Number Of Votes Allowed For Each Share CommonStockVotingRightsNumberOfVotesAllowedForEachShare	1	vote
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	41034197	shares
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised In Noncash Transaction ClassOfWarrantOrRightNumberOfWarrantsExercisedInNoncashTransaction	25966976	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173300000	usd
CY2021	lcid	Class Of Warrant Or Right Warrants Redeemed Or Called During Period Shares ClassOfWarrantOrRightWarrantsRedeemedOrCalledDuringPeriodShares	365803	shares
CY2021Q4	lcid	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	857825	shares
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	24.15
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	196330838	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Contingency Period ReverseRecapitalizationContingentConsiderationContingencyPeriod	P5Y
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Issued And Outstanding ReverseRecapitalizationContingentConsiderationSharesIssuedAndOutstanding	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Issued And Outstanding ReverseRecapitalizationContingentConsiderationWarrantsIssuedAndOutstanding	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39011116	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	224721000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4829886	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.61
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9003642	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1926225	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.83
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32911135	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.99
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	91785000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	26806933	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.17
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M12D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	86227000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.61
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	50100000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	475500000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	206700000	usd
CY2023	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	17400000	usd
CY2021	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	24000000	usd
CY2022	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5400000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5500000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6200000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	257283000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	423500000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	516757000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	43300000	usd
CY2022Q3	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	31700000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	221508000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	215160000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28431000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11269000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	244122000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	243843000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	272553000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	255112000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	85055000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90386000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	85055000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90386000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8202000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10586000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	77653000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	81336000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	85855000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	91922000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	55307000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	44617000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	31097000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1770000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1712000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2406000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5252000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4812000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3020000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4867000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2453000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	460000	usd
CY2023	lcid	Finance Lease Cost FinanceLeaseCost	10119000	usd
CY2022	lcid	Finance Lease Cost FinanceLeaseCost	7265000	usd
CY2021	lcid	Finance Lease Cost FinanceLeaseCost	3480000	usd
CY2023	us-gaap	Lease Cost LeaseCost	67196000	usd
CY2022	us-gaap	Lease Cost LeaseCost	53594000	usd
CY2021	us-gaap	Lease Cost LeaseCost	36983000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y7M6D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1101
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1052
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0559
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0557
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	44965000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	15482000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	10019000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	5430000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	509000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	460000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5425000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4977000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3088000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	32558000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	73502000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	84078000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	84392000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9693000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	56847000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	8340000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	62261000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	6619000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	59146000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	82488000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	51331000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	117000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	47464000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	37000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	120441000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	397490000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	97601000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	124937000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	11746000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	272553000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	85855000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28431000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8202000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	244122000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	77653000	usd
CY2023Q4	lcid	Lessee Lease Not Yet Commenced Undiscounted Amount LesseeLeaseNotYetCommencedUndiscountedAmount	11500000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	344793000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	462918000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	706427000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	703205000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	692764000	usd
CY2023Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	2016409000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	4926516000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2825820000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1306245000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2580324000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1574000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2164000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	612000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2827394000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1304081000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2579712000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	14000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1002000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	365000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	27000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1026000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	379000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	49000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1026000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	379000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.015
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.029
CY2023	lcid	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilityPercent	0.006
CY2022	lcid	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilityPercent	0.202
CY2021	lcid	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilityPercent	-0.085
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.015
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.003
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.014
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.007
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.193
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.428
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.100
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1240197000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	974097000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	139672000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	104678000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12322000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	26438000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	333958000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	174564000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	215087000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	100622000	usd
CY2023Q4	lcid	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	88407000	usd
CY2022Q4	lcid	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	84635000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	271784000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	21815000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	19037000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2323242000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1484071000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2137851000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1374265000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	185391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	109806000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	49754000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	39618000	usd
CY2023Q4	lcid	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	74565000	usd
CY2022Q4	lcid	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	70188000	usd
CY2023Q4	lcid	Deferred Tax Liabilities Tax Accounting Method Change DeferredTaxLiabilitiesTaxAccountingMethodChange	61072000	usd
CY2022Q4	lcid	Deferred Tax Liabilities Tax Accounting Method Change DeferredTaxLiabilitiesTaxAccountingMethodChange	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	185391000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	109806000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2137900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1374300000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	763600000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	701400000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	105234000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72330000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42894000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	539000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	581000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	35575000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	32916000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	31336000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	12000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	140767000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	105234000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72330000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	140800000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	105200000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	600000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	500000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2828420000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1304460000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2828420000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1304460000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4747093000	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	-1254218000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2828420000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2558678000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4747093000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2081772622	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1678346079	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740393759	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	14912529	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2081772622	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1693258608	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740393759	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.36
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.41
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.36
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.41
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	185235513	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126145618	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	177417887	shares
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-007209-index-headers.html	Edgar Link	pending
0001628280-24-007209-index.html	Edgar Link	pending
0001628280-24-007209.txt	Edgar Link	pending
0001628280-24-007209-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy2310k-ex1031.htm	Edgar Link	pending
fy2310k-ex1032.htm	Edgar Link	pending
fy2310k-ex1049.htm	Edgar Link	pending
fy2310k-ex211.htm	Edgar Link	pending
fy2310k-ex231.htm	Edgar Link	pending
fy2310k-ex232.htm	Edgar Link	pending
fy2310k-ex311.htm	Edgar Link	pending
fy2310k-ex312.htm	Edgar Link	pending
fy2310k-ex321.htm	Edgar Link	pending
fy2310k-ex322.htm	Edgar Link	pending
fy2310k-ex971.htm	Edgar Link	pending
lcid-20231231.htm	Edgar Link	pending
lcid-20231231.xsd	Edgar Link	pending
lcid-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
lcid-20231231_cal.xml	Edgar Link	unprocessable
lcid-20231231_def.xml	Edgar Link	unprocessable
lcid-20231231_lab.xml	Edgar Link	unprocessable
lcid-20231231_pre.xml	Edgar Link	unprocessable
lcid-20231231_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCID
Lucid Group, Inc. Stock $lcid

2024 Q1 Form 10-K Financial Statement

#000162828024007209 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID Lucid Group, Inc. Stock $lcid

2024 Q1 Form 10-K Financial Statement

#000162828024007209 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID
Lucid Group, Inc. Stock $lcid